ECF843

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ECF843, covering 2022-05-26 to 2022-05-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease [Phase 2]